All In MedTech

Device Trial Radar · NCT00766168

High Refractive Index Material 510(k)

Prospective Study of Substantial Equivalence of Rigid Gas Permeable HDS HI 1.54™ Daily Wear Lenses for Correction of Naturally Occurring Myopia and Hyperopia From +20 to - 20 D Sphere (Spectacle Plane) With and Without Astigmatism.

Last checked: Nov 20, 2026Latest source record: Jun 14, 2012 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

76

Actual

Start

Jan 2008

Primary completion

Aug 2008

Study completion Aug 2008

Sponsor

Lead sponsor
CooperVision International Limited (CVIL)Not on our public-company list
Sponsor type
Industry
First posted
Oct 3, 2008

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
Double (participant, care provider)
Primary purpose
Treatment
Who can join
All sexes, from 12 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The purpose of this study is to establish the substantial equivalence of the HDS HI 1.54™ to the paflufocon C material control lenses to correct myopia and hyperopia with and without astigmatism. The purpose of the study is to profile the outcome endpoints and the patient acceptance of this Class II medical device.

Conditions

  • Myopia
  • Hyperopia

Interventions

  • HDS HI 1.54; pahrifocon AOther

    Contact Lens

  • FluoroPerm 30 RGP; paflufocon CDevice

    Contact lens daily wear

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Best Corrected Visual Acuity vs ControlTime frame: 3 months

Locations

8 sites in 1 country. Site status is shown where the registry gives one.

  • Mission Optometry

    Lake Elsinore, California

  • Eyecare Consultants

    Englewood, Colorado

  • Vision Care Associates

    East Lansing, Michigan

5 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.